Results showed that compared with control-treated AAN mice at day 42, AAN mice received Smad7 treatment from day 14 to day 42 after induction of AAN were protected from progressive renal histological and functional injury (Fig. 7). The gene discussed is SMAD7; the disease is Balkan nephropathy.